AKR 202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AKR 202, covering 2014-10-23 to 2014-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Placebo Controlled, Double Blind, Randomised, 8-week Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of AKR 202 in Patients With Osteoarthritis Pain [Phase 2]